Pulmonale Hypertonie

Internist

Volumn 38, Issue 10, 1997, Pages 1020-1033

  Beuckelmann, D J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; PHENPROCOUMON; PROSTACYCLIN; VASODILATOR AGENT;

DOPPLER FLOWMETRY; ECHOGRAPHY; ELECTROCARDIOGRAM; HUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; SHORT SURVEY;

HUMANS; HYPERTENSION, PULMONARY; PROGNOSIS; RISK FACTORS;

EID: 0030876189     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050113     Document Type: Article

References (24)

1. L Abenhaim, Y Moride, F Brenot, St Rich, J Benichou, X Kurz, T Higenbrottam, C Oakley, E Wouters, M Aubie, G Simonneau, B Begaud (1996): Appetite-Suppressant Drugs and the risk of primary pulmonary hypertension. N Engl J Med 335:609-616
2. R A Asherson, M A Khammashta, J Ordi-Ros (1989) The primary antiphospholipid syndrome: major clinical and serologigcal features. Medicine (Baltimore) 68:366-374
3. R J Barst, L J Rubin, M D McGoon, E J Caldwell, W A Long, P S Levy (1994) Survival in Primary Pulmonary Hypertension with Long-Term continuous Intravenous Prostacyclin. Ann Intern med 121:409-415
4. R J Barst, L.J. Rubin, W A Long (1196) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334: 296-301
5. J Beyne J (1942) Influence de l'anoxemie sur la grande circulation et sur la circulation pulonaire. CR Soc Biol 136:399-400
6. 2 sensor in the pulmonary artery. Appl Physiol 66:167-170
7. AY Butt, T W Higenbottam, G Cremona, M Takao, C Glanville, A MacMahon (1993) Lack of acute pulmonary vasodilatation does not preclude successful clinical response to prostacyclin (Pg 12) in severe pulmonary hypertension (Abs). Br. Heart J p 77
8. G A D'Alonzo, R J Barst, S M Ayres et al (1991) Survival in patients with primary pulmonary hypertension: results from a National Prospective Registry. Ann Intern Med 115:343-349
9. BF Dickey, A R Myers (1988) Pulmonary manifestations of collagen-vascular diseases. In: Fishman AP(ed) Pulmonary diseases and disorders. New York, Mc Graw-Hill, Vol. 2, Part 6:645-663
10. V Fuster, P M Steele,W D Edwards, B J Gersh, M D McGoon, R L Frye (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70/4:580-587
11. W Long, L J Rubin, R Barst, S Rich, D Badesch et al (1993) Randomized trial of conventional therapy alone vs conventional therapie + continuous infusions of prostacyclin in primary pulmonary hypertension: a 12 week study (abstract). Am Rev Respir Dis 147:A538
12. K M Moser, W R Auger, P F Fedullo (1990) Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 81:1735-1743
13. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen thrapy in hypoxemic chrinic obstructive lung disease: a clinical trial. Ann Intern Med 93(3):391-398
14. H Olschewski, D Walmrath, R Schermuly, A Ghofrani, F Grimminger, W Seeger (1996) Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension. Ann Intern Med 124:820-824
15. C H Orchard, R S de Leon, M K Sykes (1983) The relationship between hypoxic pulmonary vasoconstriction and arterial oxygen tension in infect dog. J Physiol 338:61-74
16. A Ourednik, Z Susa (1977) Prognose von Patienten mit pulmonaler Hypertension bei chronisch obstruktiven Lungenerkrankungen. Atemwegs Lungenkrankh 4:124
17. J A Parrakos, S J Aldestein, Re Smith, R D Rickmann, W Grossman, L Dexter, J E Dalen (1973) Late prognosis of acute pulmonary embolism. N Engl J Med 289:55-58
18. W Petro (1998) Sauerstoff-Langzeittherapie. Thieme, Stuttgart, NewYork
19. G G Pietra, W D Edwards, J M Kay, S Rich, J T Kernis et al (1989) Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Blood and Lung Institute, Primary Pulmonary Hypertension Registry. Circulation 80:1198-12o6
20. B A Reitz, JI Wallwork, S A Hunt J I Pennock, M E Billingham, P E Oyer et al (1982) Heart-lung transplantation. N Engl J Med 306:557-564
21. S Rich, D R Dantzker, S M Ayres, et al (1987) Primary pulmonary hypertension: a national prospective study. Ann Intern Med 107:216-223
22. S Rich, E Kaufmann, P S Levy (1992) The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327:76-81
23. S C Stuart-Harris, D C Flenley, J M Bishof, et al (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1(8222): 681-686
24. C A Wagenvoort, N Wagenvoort (1970) Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 42:1163-1183